SCHEMBL29153128

SCHEMBL29153128

COC(=O)CN1C(C)CN(C(=O)O)C[C@@H]1C

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.37
POLB P06746 1/20 0.33
BRD4 O60885 1/20 0.33
KDM4E B2RXH2 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HSD17B10 Q99714 1/20 0.30
MGAM O43451 1/20 0.30
GAA P10253 1/20 0.30
SI P14410 1/20 0.30
MGAM2 Q2M2H8 1/20 0.30
MDM2 Q00987 1/20 0.30
CHRNB2 P17787 1/20 0.30
CHRNB4 P30926 1/20 0.30
CHRNA3 P32297 1/20 0.30
CHRNA4 P43681 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29153129 1.00 TSHR (0.37) TSHRPOLBBRD4KDM4ESMN1; SMN2
SCHEMBL21876568 0.83 HSD11B1 (0.38) TSHRPOLBKDM4ESMN1; SMN2MGAM
SCHEMBL29170225 0.83 SMN1; SMN2 (0.40) TSHRPOLBBRD4SMN1; SMN2
SCHEMBL4257940 0.83 HSD11B1 (0.38) TSHRPOLBKDM4ESMN1; SMN2MGAM
SCHEMBL29170224 0.83 SMN1; SMN2 (0.40) TSHRPOLBBRD4SMN1; SMN2
SCHEMBL14818161 0.81 TSHR (0.39) TSHRPOLBBRD4KDM4ESMN1; SMN2
SCHEMBL22128751 0.81 NR1H2 (0.36) KDM4ESMN1; SMN2
SCHEMBL30390162 0.81 NR1H2 (0.40) KDM4ESMN1; SMN2
SCHEMBL335294 0.79 NR1H2 (0.47) TSHRSMN1; SMN2
SCHEMBL10220897 0.79 NR1H2 (0.47) TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117561249-A Cereblon binding compounds, compositions thereof, and methods for their use in therapy 细胞基因公司 2024-02-13 CN disclosed
CN-117545752-A Cereblon binding compounds, compositions thereof, and methods for their use in therapy 细胞基因公司 2024-02-09 CN disclosed